

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to zinc ion (GO:0010043) | 5.85898187 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.62962372 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.62962372 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.48501190 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.48501190 |
| 6 | response to cadmium ion (GO:0046686) | 4.52410318 |
| 7 | glucosamine-containing compound catabolic process (GO:1901072) | 4.47657582 |
| 8 | xenobiotic catabolic process (GO:0042178) | 3.96539357 |
| 9 | aromatic amino acid family catabolic process (GO:0009074) | 3.62111086 |
| 10 | cellular zinc ion homeostasis (GO:0006882) | 3.59698449 |
| 11 | regulation of mononuclear cell migration (GO:0071675) | 3.58557214 |
| 12 | eosinophil chemotaxis (GO:0048245) | 3.45556790 |
| 13 | regulation of sequestering of triglyceride (GO:0010889) | 3.32413572 |
| 14 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.31998923 |
| 15 | amino sugar catabolic process (GO:0046348) | 3.29842016 |
| 16 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.24270077 |
| 17 | low-density lipoprotein particle clearance (GO:0034383) | 3.23219413 |
| 18 | lipid storage (GO:0019915) | 3.18761847 |
| 19 | response to nitrosative stress (GO:0051409) | 3.10955655 |
| 20 | eosinophil migration (GO:0072677) | 3.00670061 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 3.00041572 |
| 22 | response to hydroperoxide (GO:0033194) | 2.94342454 |
| 23 | acute-phase response (GO:0006953) | 2.90619555 |
| 24 | arginine catabolic process (GO:0006527) | 2.88295185 |
| 25 | cellular response to arsenic-containing substance (GO:0071243) | 2.86758132 |
| 26 | positive regulation of lipid storage (GO:0010884) | 2.84856427 |
| 27 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.77201294 |
| 28 | zinc ion homeostasis (GO:0055069) | 2.68875764 |
| 29 | regulation of phospholipase A2 activity (GO:0032429) | 2.67944898 |
| 30 | response to transition metal nanoparticle (GO:1990267) | 2.67393214 |
| 31 | triglyceride catabolic process (GO:0019433) | 2.61369677 |
| 32 | negative regulation of complement activation (GO:0045916) | 2.59844303 |
| 33 | cellular response to metal ion (GO:0071248) | 2.58217140 |
| 34 | lipid particle organization (GO:0034389) | 2.56963109 |
| 35 | positive regulation of chemokine secretion (GO:0090197) | 2.56394252 |
| 36 | cellular ketone body metabolic process (GO:0046950) | 2.54243580 |
| 37 | zinc ion transport (GO:0006829) | 2.53862456 |
| 38 | digestion (GO:0007586) | 2.50900588 |
| 39 | negative regulation of protein activation cascade (GO:2000258) | 2.49570652 |
| 40 | alanine transport (GO:0032328) | 2.47106133 |
| 41 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.44578452 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 2.42685833 |
| 43 | cell wall macromolecule metabolic process (GO:0044036) | 2.42110456 |
| 44 | negative regulation of membrane potential (GO:0045837) | 2.41904714 |
| 45 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.40850434 |
| 46 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.40671308 |
| 47 | complement activation, alternative pathway (GO:0006957) | 2.40395114 |
| 48 | fatty acid homeostasis (GO:0055089) | 2.40339087 |
| 49 | negative regulation of viral entry into host cell (GO:0046597) | 2.39783022 |
| 50 | zinc ion transmembrane transport (GO:0071577) | 2.39421845 |
| 51 | C4-dicarboxylate transport (GO:0015740) | 2.38453730 |
| 52 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38407708 |
| 53 | acylglycerol catabolic process (GO:0046464) | 2.37576384 |
| 54 | neutral lipid catabolic process (GO:0046461) | 2.37576384 |
| 55 | triglyceride homeostasis (GO:0070328) | 2.36525088 |
| 56 | acylglycerol homeostasis (GO:0055090) | 2.36525088 |
| 57 | lymphocyte chemotaxis (GO:0048247) | 2.35994388 |
| 58 | tyrosine metabolic process (GO:0006570) | 2.35908469 |
| 59 | negative regulation of lipid catabolic process (GO:0050995) | 2.35897289 |
| 60 | pyrimidine-containing compound salvage (GO:0008655) | 2.34958769 |
| 61 | pyrimidine nucleoside salvage (GO:0043097) | 2.34958769 |
| 62 | fibrinolysis (GO:0042730) | 2.29814482 |
| 63 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.28864889 |
| 64 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.28772309 |
| 65 | regulation of transmission of nerve impulse (GO:0051969) | 2.28260051 |
| 66 | macrophage chemotaxis (GO:0048246) | 2.27840455 |
| 67 | opsonization (GO:0008228) | 2.27167136 |
| 68 | regulation of metalloenzyme activity (GO:0048552) | 2.26473605 |
| 69 | acute inflammatory response (GO:0002526) | 2.26131812 |
| 70 | regulation of macrophage chemotaxis (GO:0010758) | 2.25509048 |
| 71 | signal peptide processing (GO:0006465) | 2.24569061 |
| 72 | response to dietary excess (GO:0002021) | 2.23256599 |
| 73 | DNA deamination (GO:0045006) | 2.20557835 |
| 74 | regulation of chemokine secretion (GO:0090196) | 2.20487262 |
| 75 | cellular response to inorganic substance (GO:0071241) | 2.20112976 |
| 76 | negative regulation of lipase activity (GO:0060192) | 2.19586876 |
| 77 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.18305123 |
| 78 | mannosylation (GO:0097502) | 2.17298995 |
| 79 | iron ion import (GO:0097286) | 2.17258609 |
| 80 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.15880512 |
| 81 | virion attachment to host cell (GO:0019062) | 2.15819930 |
| 82 | adhesion of symbiont to host cell (GO:0044650) | 2.15819930 |
| 83 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.15814899 |
| 84 | regulation of triglyceride metabolic process (GO:0090207) | 2.14500378 |
| 85 | negative regulation of protein autophosphorylation (GO:0031953) | 2.14117213 |
| 86 | biotin metabolic process (GO:0006768) | 2.14050213 |
| 87 | vitamin biosynthetic process (GO:0009110) | 2.13984829 |
| 88 | regulation of chemokine biosynthetic process (GO:0045073) | 2.13427292 |
| 89 | transcytosis (GO:0045056) | 2.13303046 |
| 90 | ketone body metabolic process (GO:1902224) | 2.13247838 |
| 91 | negative regulation of focal adhesion assembly (GO:0051895) | 2.11592442 |
| 92 | negative regulation of cell junction assembly (GO:1901889) | 2.11592442 |
| 93 | negative regulation of adherens junction organization (GO:1903392) | 2.11592442 |
| 94 | glycerolipid catabolic process (GO:0046503) | 2.11308224 |
| 95 | glutathione derivative metabolic process (GO:1901685) | 2.11085805 |
| 96 | glutathione derivative biosynthetic process (GO:1901687) | 2.11085805 |
| 97 | negative regulation of lipid storage (GO:0010888) | 2.10879354 |
| 98 | cofactor catabolic process (GO:0051187) | 2.10161449 |
| 99 | cellular response to zinc ion (GO:0071294) | 16.4400810 |
| 100 | cellular response to cadmium ion (GO:0071276) | 10.7425624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.12046058 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.00195170 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.94777315 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.85916553 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.47799475 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71701379 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57833153 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57099860 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.54223588 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.35604112 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.35388148 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.27237553 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.23435980 |
| 14 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.20275796 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13408153 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.09155600 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.96688556 |
| 18 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.95346525 |
| 19 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.94642168 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.92755206 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.89239635 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.85160811 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80678474 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.78774004 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.69284608 |
| 26 | CJUN_26792858_Chip-Seq_BT549_Human | 1.67793238 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62249835 |
| 28 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.57867951 |
| 29 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.54566807 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53034119 |
| 31 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50305987 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50007692 |
| 33 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44443541 |
| 34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.44259022 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43148154 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42368689 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42195338 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41734149 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37866217 |
| 40 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33643656 |
| 41 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.33349711 |
| 42 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.31912397 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28694197 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27499018 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26716046 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25319560 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23503061 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.19383211 |
| 49 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.16084319 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15374613 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12709619 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12581231 |
| 53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11920269 |
| 54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11920269 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11398550 |
| 56 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.09720746 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09360432 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08596756 |
| 59 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.05793113 |
| 60 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.04060405 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03994573 |
| 62 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03637115 |
| 63 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00092988 |
| 64 | CBP_21632823_ChIP-Seq_H3396_Human | 0.99339543 |
| 65 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97969265 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.97660053 |
| 67 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.97187247 |
| 68 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.96712163 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.96340028 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94175877 |
| 71 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.94133653 |
| 72 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.94133653 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93267114 |
| 74 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.91362005 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88165340 |
| 76 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87977615 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87673832 |
| 78 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86942581 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86527632 |
| 80 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.84353898 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.83393206 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83013482 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82431045 |
| 84 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80839373 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80498871 |
| 86 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.80063582 |
| 87 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.79870646 |
| 88 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.77747898 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77536945 |
| 90 | NCOR_22424771_ChIP-Seq_293T_Human | 0.76024606 |
| 91 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.75143071 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.74586522 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.73625715 |
| 94 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73573987 |
| 95 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.73287373 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72958914 |
| 97 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72640435 |
| 98 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.71975119 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71837150 |
| 100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.71620211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.28731829 |
| 2 | MP0003195_calcinosis | 3.87669952 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.18200418 |
| 4 | MP0009785_altered_susceptibility_to | 3.02257652 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.78966470 |
| 6 | MP0000343_altered_response_to | 2.73625297 |
| 7 | MP0004510_myositis | 2.65345854 |
| 8 | MP0009840_abnormal_foam_cell | 2.44544370 |
| 9 | MP0005670_abnormal_white_adipose | 2.36350938 |
| 10 | MP0003950_abnormal_plasma_membrane | 2.35371227 |
| 11 | MP0001853_heart_inflammation | 2.30529190 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.24101926 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.08513619 |
| 14 | MP0005332_abnormal_amino_acid | 2.05978116 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.04005173 |
| 16 | MP0003011_delayed_dark_adaptation | 2.01633235 |
| 17 | MP0005365_abnormal_bile_salt | 1.99046748 |
| 18 | MP0003075_altered_response_to | 1.95554013 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 1.91835031 |
| 20 | MP0006082_CNS_inflammation | 1.88787552 |
| 21 | MP0002971_abnormal_brown_adipose | 1.88145566 |
| 22 | MP0009764_decreased_sensitivity_to | 1.86330019 |
| 23 | MP0003186_abnormal_redox_activity | 1.75499833 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.60297083 |
| 25 | MP0001764_abnormal_homeostasis | 1.59936863 |
| 26 | MP0005023_abnormal_wound_healing | 1.56127191 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.52388739 |
| 28 | MP0003436_decreased_susceptibility_to | 1.51022949 |
| 29 | MP0002254_reproductive_system_inflammat | 1.49593413 |
| 30 | MP0005164_abnormal_response_to | 1.47390731 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.44012296 |
| 32 | MP0000604_amyloidosis | 1.42826441 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.38025200 |
| 34 | MP0008469_abnormal_protein_level | 1.36210693 |
| 35 | MP0005360_urolithiasis | 1.36183640 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33018162 |
| 37 | MP0005166_decreased_susceptibility_to | 1.30580396 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.30357690 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.28461421 |
| 40 | MP0003045_fibrosis | 1.27106090 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.26058437 |
| 42 | MP0005595_abnormal_vascular_smooth | 1.25788637 |
| 43 | MP0005387_immune_system_phenotype | 1.24359716 |
| 44 | MP0001790_abnormal_immune_system | 1.24359716 |
| 45 | MP0008004_abnormal_stomach_pH | 1.23956138 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.23242154 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.23143984 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.21747025 |
| 49 | MP0005535_abnormal_body_temperature | 1.19915523 |
| 50 | MP0002419_abnormal_innate_immunity | 1.17769449 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.16723366 |
| 52 | MP0005334_abnormal_fat_pad | 1.15012179 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.14815362 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.13848868 |
| 55 | MP0005448_abnormal_energy_balance | 1.13374928 |
| 56 | MP0002693_abnormal_pancreas_physiology | 1.13045986 |
| 57 | MP0003633_abnormal_nervous_system | 1.12358628 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.12138965 |
| 59 | MP0002970_abnormal_white_adipose | 1.11248547 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.09877210 |
| 61 | MP0005375_adipose_tissue_phenotype | 1.08985270 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.07670222 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.07642839 |
| 64 | MP0001542_abnormal_bone_strength | 1.07436042 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.07054176 |
| 66 | MP0005410_abnormal_fertilization | 1.06536603 |
| 67 | MP0009763_increased_sensitivity_to | 1.06345576 |
| 68 | MP0005025_abnormal_response_to | 1.05259838 |
| 69 | MP0004883_abnormal_blood_vessel | 1.05071614 |
| 70 | MP0009046_muscle_twitch | 1.04236352 |
| 71 | MP0004947_skin_inflammation | 1.04036624 |
| 72 | MP0002168_other_aberrant_phenotype | 1.03837329 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 1.01546330 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.01003848 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.00576683 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.99929025 |
| 77 | MP0000609_abnormal_liver_physiology | 0.97871736 |
| 78 | MP0000427_abnormal_hair_cycle | 0.97861382 |
| 79 | MP0003724_increased_susceptibility_to | 0.97376351 |
| 80 | MP0005165_increased_susceptibility_to | 0.95823651 |
| 81 | MP0010307_abnormal_tumor_latency | 0.95614091 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.95137289 |
| 83 | MP0008775_abnormal_heart_ventricle | 0.91882373 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.91521590 |
| 85 | MP0000685_abnormal_immune_system | 0.90633383 |
| 86 | MP0003303_peritoneal_inflammation | 0.90465870 |
| 87 | MP0005397_hematopoietic_system_phenotyp | 0.89528553 |
| 88 | MP0001545_abnormal_hematopoietic_system | 0.89528553 |
| 89 | MP0003448_altered_tumor_morphology | 0.88794014 |
| 90 | MP0010678_abnormal_skin_adnexa | 0.88517359 |
| 91 | MP0008438_abnormal_cutaneous_collagen | 0.87846650 |
| 92 | MP0003279_aneurysm | 0.86604075 |
| 93 | MP0009278_abnormal_bone_marrow | 0.84250782 |
| 94 | MP0001756_abnormal_urination | 0.82082790 |
| 95 | MP0005671_abnormal_response_to | 0.80725391 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.79436701 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.79149827 |
| 98 | MP0001881_abnormal_mammary_gland | 0.78788920 |
| 99 | MP0003329_amyloid_beta_deposits | 0.78362746 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.77010684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.14924708 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.17132525 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.17132525 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.17132525 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 3.71055894 |
| 6 | Complement deficiency (HP:0004431) | 3.36445590 |
| 7 | Xanthomatosis (HP:0000991) | 3.21828410 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 3.06719579 |
| 9 | Progressive neurologic deterioration (HP:0002344) | 3.03912120 |
| 10 | Renal Fanconi syndrome (HP:0001994) | 3.03652253 |
| 11 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.98263768 |
| 12 | Hypokinesia (HP:0002375) | 2.87281844 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.81257025 |
| 14 | Opisthotonus (HP:0002179) | 2.79443136 |
| 15 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.72900098 |
| 16 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.72900098 |
| 17 | Abnormal protein glycosylation (HP:0012346) | 2.72900098 |
| 18 | Abnormal glycosylation (HP:0012345) | 2.72900098 |
| 19 | Abnormality of complement system (HP:0005339) | 2.69906416 |
| 20 | Dysostosis multiplex (HP:0000943) | 2.64409020 |
| 21 | Hepatic necrosis (HP:0002605) | 2.64383290 |
| 22 | 3-Methylglutaconic aciduria (HP:0003535) | 2.59668289 |
| 23 | Hepatocellular necrosis (HP:0001404) | 2.56868199 |
| 24 | Acute hepatic failure (HP:0006554) | 2.51066465 |
| 25 | Axonal loss (HP:0003447) | 2.49276433 |
| 26 | Ketoacidosis (HP:0001993) | 2.47933578 |
| 27 | Vascular calcification (HP:0004934) | 2.46512054 |
| 28 | Bone cyst (HP:0012062) | 2.45256011 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43717811 |
| 30 | Symptomatic seizures (HP:0011145) | 2.40394661 |
| 31 | Hypertriglyceridemia (HP:0002155) | 2.39507988 |
| 32 | Mitochondrial inheritance (HP:0001427) | 2.38283504 |
| 33 | Epidermoid cyst (HP:0200040) | 2.37295672 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36985192 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36985192 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36985192 |
| 37 | Generalized aminoaciduria (HP:0002909) | 2.36029463 |
| 38 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.32425776 |
| 39 | Glomerulonephritis (HP:0000099) | 2.31488164 |
| 40 | Hyperglycemia (HP:0003074) | 2.30560589 |
| 41 | Hematochezia (HP:0002573) | 2.29060261 |
| 42 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.28584073 |
| 43 | Insulin resistance (HP:0000855) | 2.26246502 |
| 44 | Ketosis (HP:0001946) | 2.26234866 |
| 45 | Horizontal nystagmus (HP:0000666) | 2.23609057 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.22532177 |
| 47 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.22040365 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.21664006 |
| 49 | Increased CSF protein (HP:0002922) | 2.20427701 |
| 50 | Episodic fever (HP:0001954) | 2.18226778 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16488045 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.16488045 |
| 53 | Abnormality of renal resorption (HP:0011038) | 2.12637873 |
| 54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12371719 |
| 55 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12371719 |
| 56 | Abnormality of macrophages (HP:0004311) | 2.11345011 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.10668713 |
| 58 | Myocardial infarction (HP:0001658) | 2.08911192 |
| 59 | Craniofacial dystonia (HP:0012179) | 2.08236447 |
| 60 | Focal dystonia (HP:0004373) | 2.08187426 |
| 61 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.07854749 |
| 62 | Torticollis (HP:0000473) | 2.07038917 |
| 63 | Acute necrotizing encephalopathy (HP:0006965) | 2.06396168 |
| 64 | Hyperammonemia (HP:0001987) | 2.05968853 |
| 65 | Acanthosis nigricans (HP:0000956) | 2.04929921 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.04081851 |
| 67 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.02894191 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 1.99633954 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99633954 |
| 70 | Abnormality of the basal ganglia (HP:0002134) | 1.98128772 |
| 71 | Petechiae (HP:0000967) | 1.97252670 |
| 72 | Abnormality of alanine metabolism (HP:0010916) | 1.96627523 |
| 73 | Hyperalaninemia (HP:0003348) | 1.96627523 |
| 74 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.96627523 |
| 75 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.96217718 |
| 76 | Prolonged neonatal jaundice (HP:0006579) | 1.94222415 |
| 77 | Severe visual impairment (HP:0001141) | 1.94122516 |
| 78 | Glucose intolerance (HP:0000833) | 1.91670674 |
| 79 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91548244 |
| 80 | Progressive macrocephaly (HP:0004481) | 1.91134519 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 1.90028834 |
| 82 | Hypoglycemic coma (HP:0001325) | 1.89671597 |
| 83 | Pendular nystagmus (HP:0012043) | 1.89403953 |
| 84 | Prolonged partial thromboplastin time (HP:0003645) | 1.89201059 |
| 85 | Glycosuria (HP:0003076) | 1.88574223 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 1.88574223 |
| 87 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.85153234 |
| 88 | Increased CSF lactate (HP:0002490) | 1.83748828 |
| 89 | Hemiparesis (HP:0001269) | 1.83642768 |
| 90 | Lipid accumulation in hepatocytes (HP:0006561) | 1.83506607 |
| 91 | CNS demyelination (HP:0007305) | 1.82258147 |
| 92 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.81564444 |
| 93 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.81564444 |
| 94 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.81492739 |
| 95 | Joint hemorrhage (HP:0005261) | 1.81190584 |
| 96 | Abnormality of the periventricular white matter (HP:0002518) | 1.79713367 |
| 97 | Ileus (HP:0002595) | 1.79043470 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 1.78650053 |
| 99 | Abnormal glucose tolerance (HP:0001952) | 1.77892761 |
| 100 | Malnutrition (HP:0004395) | 1.75984786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.51822624 |
| 2 | MUSK | 4.49957120 |
| 3 | MAP3K3 | 3.03381654 |
| 4 | FRK | 2.51193436 |
| 5 | IRAK3 | 2.41965565 |
| 6 | MAP4K2 | 2.16647582 |
| 7 | PDK2 | 2.10237383 |
| 8 | MAP3K13 | 2.08722176 |
| 9 | TESK1 | 2.06100300 |
| 10 | MYLK | 1.93255531 |
| 11 | ERBB4 | 1.92579748 |
| 12 | NME2 | 1.91981636 |
| 13 | KDR | 1.84543147 |
| 14 | MST4 | 1.84081435 |
| 15 | LIMK1 | 1.78493397 |
| 16 | MAP3K11 | 1.66384270 |
| 17 | ADRBK2 | 1.60712759 |
| 18 | GRK7 | 1.59667598 |
| 19 | TAOK2 | 1.57338529 |
| 20 | ERN1 | 1.56755416 |
| 21 | BLK | 1.53157296 |
| 22 | ABL2 | 1.51032462 |
| 23 | IKBKB | 1.48686694 |
| 24 | TGFBR2 | 1.46379829 |
| 25 | TESK2 | 1.38817661 |
| 26 | EIF2AK3 | 1.36054745 |
| 27 | FER | 1.34998603 |
| 28 | MAP3K9 | 1.31444268 |
| 29 | GSK3A | 1.30342266 |
| 30 | ARAF | 1.23696183 |
| 31 | TRPM7 | 1.23246922 |
| 32 | GRK1 | 1.20469414 |
| 33 | DDR2 | 1.18103301 |
| 34 | MOS | 1.15727122 |
| 35 | MAP3K1 | 1.14839685 |
| 36 | PHKG2 | 1.14101204 |
| 37 | PHKG1 | 1.14101204 |
| 38 | LMTK2 | 1.13821377 |
| 39 | PAK4 | 1.12697068 |
| 40 | ZAK | 1.11598177 |
| 41 | EPHA3 | 1.10459220 |
| 42 | PRKG2 | 1.07877810 |
| 43 | EPHB1 | 1.06966417 |
| 44 | IRAK1 | 1.04851699 |
| 45 | MARK3 | 1.02127494 |
| 46 | BCKDK | 1.00756365 |
| 47 | MAP3K14 | 1.00049060 |
| 48 | CLK1 | 0.99932523 |
| 49 | MAPKAPK3 | 0.98226727 |
| 50 | STK16 | 0.96551761 |
| 51 | PINK1 | 0.96239816 |
| 52 | DAPK2 | 0.91654076 |
| 53 | MAP3K5 | 0.88871087 |
| 54 | PIM2 | 0.88806610 |
| 55 | JAK1 | 0.86165878 |
| 56 | TAOK1 | 0.86130258 |
| 57 | ZAP70 | 0.86088795 |
| 58 | ADRBK1 | 0.85810585 |
| 59 | CSK | 0.85496465 |
| 60 | PRKAA2 | 0.83458172 |
| 61 | PKN1 | 0.80935663 |
| 62 | TBK1 | 0.78691411 |
| 63 | MAP3K2 | 0.77651058 |
| 64 | CAMK2G | 0.76931538 |
| 65 | AKT3 | 0.69710547 |
| 66 | IKBKE | 0.64980359 |
| 67 | CHUK | 0.64133384 |
| 68 | CAMK2D | 0.63927194 |
| 69 | EPHA2 | 0.62608232 |
| 70 | DAPK1 | 0.61975192 |
| 71 | MST1R | 0.60851443 |
| 72 | PTK2 | 0.60245978 |
| 73 | SCYL2 | 0.59891936 |
| 74 | BUB1 | 0.57934510 |
| 75 | TYK2 | 0.56403544 |
| 76 | CAMKK2 | 0.55978324 |
| 77 | PDK1 | 0.55229657 |
| 78 | TLK1 | 0.54252315 |
| 79 | PAK3 | 0.51058253 |
| 80 | ABL1 | 0.49972716 |
| 81 | BMPR2 | 0.47995978 |
| 82 | PAK1 | 0.47243608 |
| 83 | HIPK2 | 0.44197396 |
| 84 | FLT3 | 0.44134092 |
| 85 | MAP4K1 | 0.43214957 |
| 86 | ROCK1 | 0.42514833 |
| 87 | PRKCE | 0.40892404 |
| 88 | IGF1R | 0.39777923 |
| 89 | EPHB2 | 0.39716046 |
| 90 | JAK2 | 0.39014813 |
| 91 | PRKCI | 0.38809867 |
| 92 | DAPK3 | 0.38034164 |
| 93 | PRKACG | 0.37590502 |
| 94 | MAPK7 | 0.36501728 |
| 95 | CSF1R | 0.35457003 |
| 96 | AKT2 | 0.33472649 |
| 97 | PTK2B | 0.32737903 |
| 98 | CAMK2A | 0.32206043 |
| 99 | INSR | 0.32102533 |
| 100 | PRKCG | 0.30703175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mineral absorption_Homo sapiens_hsa04978 | 5.44073277 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.60487179 |
| 3 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.42079383 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29275436 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.05973096 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.01600681 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.99399226 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.97616610 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.93081882 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84657302 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76637138 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75707692 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69914568 |
| 14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.68614105 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 1.67998400 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63549112 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.61711036 |
| 18 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.59617761 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57933589 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52489737 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47349937 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.46333328 |
| 23 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43823019 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40054645 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.38066168 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.32777976 |
| 27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.32120073 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.29536231 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27646364 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27550635 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24135246 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23555228 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22746249 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21560316 |
| 35 | Protein export_Homo sapiens_hsa03060 | 1.21188991 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19033197 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15544355 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13511182 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13211680 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12259619 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10040365 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09305713 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08766324 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07643882 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.06618918 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04325572 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 1.03860358 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03341458 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98555869 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.98433349 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98220328 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98191406 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.96311815 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96197159 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94298597 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92580022 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89854135 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88634348 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86632401 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86133711 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86085491 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83598763 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80592313 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80570137 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73753041 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73680833 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72850753 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71926038 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70961329 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69953323 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69749889 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69022695 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.68129918 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62982119 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62469232 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60927553 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60255807 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60189508 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.58954698 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57843701 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56924859 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56633293 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56608036 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56262665 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55361497 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55224103 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.54721272 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53290633 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51882991 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51462075 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49470298 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49357301 |
| 93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44461227 |
| 94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40876835 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40672012 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39476662 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.38910458 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38687016 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37753694 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37633912 |

